Results 151 to 160 of about 17,322 (222)

Optimizing metabolic management on integrase-based ART (OPTIMAR): study protocol for a 2 × 2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic risk. [PDF]

Trials
Nyein PP, Haskelberg H, Martinello M, Lowe M, Goodman-Meza D, Avihingsanon A, Kelleher AD, Rodgers A, Schutte AE, Nnakelu EC, Byakwaga H, Trevillyan J, Losso M, Kumarasamy N, Azwa RISR, Kaplan R, Clifton B, Arnott C, Dharan NJ, Petoumenos K, Matthews GV.   +20 more
europepmc   +1 more source

Recent Developments in HIV Antivirals: The Prospect of Prophylactic Drugs to Change the Pandemic. [PDF]

Microb Biotechnol
Brüssow H.
europepmc   +1 more source

Nucleoside-Analog Reverse-Transcriptase Inhibitors (NRTIs) Against Multiple Sclerosis: Comprehensive Review on a Possible Novel Therapeutic Approach. [PDF]

Neurol Int
Martinisi A, Paganetti P.
europepmc   +1 more source

Association between plasma concentrations of integrase strand transfer inhibitors and body weight gain in women with HIV. [PDF]

AIDS
Lahiri CD, Soibi-Harry AP, Musonge-Effoe J, Alvarez JA, Dumond JB, Mehta CC, Yang Q, Sheth AN, Ofotokun I, Sykes C, Hartauer M, Khoei A, Alcaide ML, Rubin LH, Konkle-Parker D, Floris-Moore M, Topper EF, French AL, Cocohoba J, Kassaye S, Augenbraun M, Sharma A, Tien PC.   +22 more
europepmc   +1 more source

Health-related quality of life in people living with HIV on first-line INSTI versus those switched from EFV to INSTI: a cross-sectional study from four cities in China. [PDF]

BMC Infect Dis
Jia H, Geng Y, Guan Y, Meng Z, Ling X, Ma P, Shao Y, Wei H, Liu X, Zhao Y.   +9 more
europepmc   +1 more source

Leveraging the Oxford Nanopore MinION sequencing platform for HIV-1 drug resistance surveillance in resource-limited settings: a post-COVID implementation opportunity. [PDF]

Virol J
Washaya T, Chimukangara B, Mayini J, Bote S, Chin'ombe N, Munyati S, Manasa J.   +6 more
europepmc   +1 more source

Harnessing machine learning models to repurpose drugs targeting HIV-1 integrase, protease, and reverse transcriptase. [PDF]

Sci Rep
Chirila CB, Crisan L.
europepmc   +1 more source

Anti-HIV-1 Activity of the Integrase Strand Transfer Inhibitor ACC017. [PDF]

Viruses
Ma MD, Luo RH, Li CY, Huang GC, Long XY, He FY, Yang LM, Fu HL, Zheng YT.   +8 more
europepmc   +1 more source

Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-experienced people with HIV-1: a systematic literature review and network meta-analysis. [PDF]

J Comp Eff Res
Curteis T, Eddowes LA, Karlsson A, Luedke H, Rubinstein M, Hempfling M, Gurney J, Gandhi-Patel B, Unger N, Mordi U, Chen M, Jarrett J, Sherman EM, Mounzer K, Khalsa AM, Dinges WL, McKellar MS, Lipps A.   +17 more
europepmc   +1 more source